APA (7th ed.) Citation

Asaki, T., Kuwano, K., Morrison, K., Gatfield, J., Hamamoto, T., & Clozel, M. (2015). Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry, 58(18), 7128-7137. https://doi.org/10.1021/acs.jmedchem.5b00698

Chicago Style (17th ed.) Citation

Asaki, Tetsuo, Keiichi Kuwano, Keith Morrison, John Gatfield, Taisuke Hamamoto, and Martine Clozel. "Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension." Journal of Medicinal Chemistry 58, no. 18 (2015): 7128-7137. https://doi.org/10.1021/acs.jmedchem.5b00698.

MLA (9th ed.) Citation

Asaki, Tetsuo, et al. "Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension." Journal of Medicinal Chemistry, vol. 58, no. 18, 2015, pp. 7128-7137, https://doi.org/10.1021/acs.jmedchem.5b00698.